Extensive research has demonstrated that Urolithin A can inhibit signaling pathways including mTOR, PI3K/Akt, and ERK in T cells, nerve cells, and tumor cells [40,41,42], highlighting its therapeutic potential in treating tumors and neurological disorders. The gene discussed is AKT1; the disease is nervous system disorder.